Cargando…

HLA‐associated adverse drug reactions ‐ scoping review

Alleles of the human leukocyte antigen (HLA) system have been associated with the occurrence of idiosyncratic adverse drug reactions (ADRs). Accordingly, it is assumed that pre‐emptive testing for the presence of certain HLA alleles (HLA‐typing) could prevent these ADRs in carriers. In order to perc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeiziner, Chiara, Wernli, Ursina, Suter, Katja, Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504845/ https://www.ncbi.nlm.nih.gov/pubmed/34105877 http://dx.doi.org/10.1111/cts.13062

Ejemplares similares

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetic information in Swiss drug labels – a systematic analysis
por: Jeiziner, C., et al.
Publicado: (2020)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps
por: Boeni, Fabienne, et al.
Publicado: (2014)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
por: Stäuble, Céline K., et al.
Publicado: (2022)

Clinical relevance of St. John's wort drug interactions revisited
por: Nicolussi, Simon, et al.
Publicado: (2020)

HLA Association with Drug-Induced Adverse Reactions
por: Fan, Wen-Lang, et al.
Publicado: (2017)

Pharmacists’ clinical roles and activities in inpatient hospice and palliative care: a scoping review
por: Wernli, Ursina, et al.
Publicado: (2023)

A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
por: Ghattaoraya, Gurpreet S., et al.
Publicado: (2016)

Adverse drug reactions in primary care: a scoping review
por: Khalil, H., et al.
Publicado: (2020)

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2017)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications
por: Schäfer, Anima M., et al.
Publicado: (2021)

Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review
por: Fossouo Tagne, Joel, et al.
Publicado: (2023)

Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4‐methylaminoantipyrine
por: Bachmann, Fabio, et al.
Publicado: (2021)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017)

Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review
por: Lardon, Jérémy, et al.
Publicado: (2015)

Mobile apps for quick adverse drug reaction report: A scoping review
por: Parracha, Edna Ribeiro, et al.
Publicado: (2022)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
por: Wittwer, Nina L, et al.
Publicado: (2022)

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
por: González-Galarza, Faviel F., et al.
Publicado: (2014)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs
por: Zhang, Jingang, et al.
Publicado: (2018)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report
por: Meyer zu Schwabedissen, Henriette E, et al.
Publicado: (2014)

PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism
por: Ehrsam, Daniel, et al.
Publicado: (2019)

Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis
por: Hakkarainen, Katja M., et al.
Publicado: (2012)

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions
por: Ramsbottom, Kerry A., et al.
Publicado: (2018)

An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese
por: Jiang, Menglin, et al.
Publicado: (2023)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)

Development of the Swiss Database for dosing medicinal products in pediatrics
por: Tilen, Romy, et al.
Publicado: (2021)

Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta
por: Taggi, Valerio, et al.
Publicado: (2022)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
por: Kinzi, Jonny, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_25s69d8vlrubc1mtcmbg76u4iu